Outlines and elaborating EuropaBio’s position and policy recommendations to the European Commission (EC)
EuropaBio has released a white paper with recommedations to the European Commission to ensure the EU remains a leader in ATMP innovation. These recommendations are broken up into short term, mid term and long term measures focussing on Clinical Trials, Genetically Modified Organism and Optimised Evidence requirements. You can find the full document here.
As a quick summary recommendations for;
The European Association for Bioindustries (EuropaBio) represents 81 corporate and associate members and bio regions, and 15 national biotechnology associations in turn representing over 1800 biotech SMEs at a Member State level. They are the recognised voice of the European biotech community championing world-class solutions for society’s challenges.
Find out more here.